Revolutionary Drug Counteracts Bone Loss in Astronauts on Moon and Mars Missions

Scientists have developed a new drug, BP-NELL-PEG, that shows potential in promoting bone formation and combating bone loss in astronauts during long-term space missions. The drug, which targets the formation of new bone, was tested on mice aboard the International Space Station (ISS) and demonstrated a significant increase in bone density. The modified drug, with an extended half-life, displayed superior specificity for bone tissue without adverse effects. While the drug has shown promising results in mice, further research is needed before it can be used for humans. The study aims to find ways to prevent the detrimental effects of microgravity on bones during spaceflight.